Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Does anyone seen the Advertisement
View:
Post by gonefishing2022 on Dec 21, 2023 9:45pm

Does anyone seen the Advertisement

It says 63 of 100 treated and 100 percent enrollment by end of 2024 and done by 2026.What am I missing I thought 100 people where Treated and just waiting on results and approval
Comment by Alamir1111 on Dec 21, 2023 10:33pm
Scroll up to Sh top page and you get a big green tabloid explaining things
Comment by Alamir1111 on Dec 21, 2023 10:45pm
Like the colour green its a subtle  message means go green pastures etc
Comment by DJDawg on Dec 21, 2023 11:37pm
Nope. 63 treated. Goal is 100 as that is the most typical goal. They are laying this out in the most conservative fashion possible as RDW was burned in the past for seeming to promise things or build up expectations ahead of time (about a physiotherapy laser). The real hope is that even before the enrollment is 100 that the numbers are good enough to warrant BTD, and even AA. It's about stats ...more  
Comment by StevenBirch on Dec 22, 2023 8:35am
Would BTD help speed up the enrollment? If it were me I would first consider the superior results, the ridiculous low number of treatments compared to the competition and of course the safety profile but for those that need more validation an approval from the FDA wouldn't hurt. As you say they don't really need 100 patients to be considered for BTD and AA but it would complete Phase II ...more  
Comment by tdon1229 on Dec 22, 2023 9:30am
Gonefishing2022, You're entitled to your own thoughts, but in this case, obviously, you thought wrong.
Comment by gebremeskel on Dec 22, 2023 4:22pm
Gonefishing wrote: "What am I missing" The news releases.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250